Literature DB >> 6724104

Properties of bovine luteal cytochrome P-450scc incorporated into artificial phospholipid vesicles.

R C Tuckey, P M Stevenson.   

Abstract

Bovine luteal cytochrome P-450scc was purified and incorporated into artificial phosphatidylcholine vesicles. The vesicle reconstituted cytochrome used membrane bound cholesterol as substrate and cholesterol binding varied with the phosphatidylcholine fatty acyl composition and was stimulated by the presence of cardiolipin in the vesicle. 22R -hydroxycholesterol and 20 alpha, 22R - dihydroxycholesterol bound to the cytochrome up to 300 times more tightly than cholesterol and decreased the affinity of the cytochrome for CO by 100-200-fold. The properties of the cytochrome closely paralleled those reported for cytochrome P-450scc purified from the bovine adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724104     DOI: 10.1016/0020-711x(84)90166-6

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  13 in total

1.  An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2.

Authors:  Andrzej Slominski; Igor Semak; Jacobo Wortsman; Jordan Zjawiony; Wei Li; Blazej Zbytek; Robert C Tuckey
Journal:  FEBS J       Date:  2006-07       Impact factor: 5.542

2.  Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.

Authors:  Robert C Tuckey; Wei Li; Haleem Z Shehabi; Zorica Janjetovic; Minh N Nguyen; Tae-Kang Kim; Jianjun Chen; Danielle E Howell; Heather A E Benson; Trevor Sweatman; Donna M Baldisseri; Andrzej Slominski
Journal:  Drug Metab Dispos       Date:  2011-06-15       Impact factor: 3.922

3.  Active Site Structures of CYP11A1 in the Presence of Its Physiological Substrates and Alterations upon Binding of Adrenodoxin.

Authors:  Qianhong Zhu; Piotr J Mak; Robert C Tuckey; James R Kincaid
Journal:  Biochemistry       Date:  2017-10-20       Impact factor: 3.162

4.  The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism.

Authors:  Andrzej Slominski; Igor Semak; Jordan Zjawiony; Jacobo Wortsman; Wei Li; Andre Szczesniewski; Robert C Tuckey
Journal:  FEBS J       Date:  2005-08       Impact factor: 5.542

5.  Lumisterol is metabolized by CYP11A1: discovery of a new pathway.

Authors:  Robert C Tuckey; Andrzej T Slominski; Chloe Y S Cheng; Jianjun Chen; Tae-Kang Kim; Min Xiao; Wei Li
Journal:  Int J Biochem Cell Biol       Date:  2014-08-13       Impact factor: 5.085

6.  A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin.

Authors:  Andrzej Slominski; Jordan Zjawiony; Jacobo Wortsman; Igor Semak; Jeremy Stewart; Alexander Pisarchik; Trevor Sweatman; Josep Marcos; Chuck Dunbar; Robert C Tuckey
Journal:  Eur J Biochem       Date:  2004-11

7.  Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin.

Authors:  Robert C Tuckey; Minh N Nguyen; Andrzej Slominski
Journal:  Int J Biochem Cell Biol       Date:  2008-05-20       Impact factor: 5.085

8.  Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc.

Authors:  Robert C Tuckey; Wei Li; Jordan K Zjawiony; Michal A Zmijewski; Minh N Nguyen; Trevor Sweatman; Duane Miller; Andrzej Slominski
Journal:  FEBS J       Date:  2008-04-10       Impact factor: 5.542

9.  Metabolism of vitamin d2 to 17,20,24-trihydroxyvitamin d2 by cytochrome p450scc (CYP11A1).

Authors:  Minh N Nguyen; Andrzej Slominski; Wei Li; Yun Rui Ng; Robert C Tuckey
Journal:  Drug Metab Dispos       Date:  2008-12-30       Impact factor: 3.922

10.  Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3.

Authors:  Robert C Tuckey; Zorica Janjetovic; Wei Li; Minh N Nguyen; Michal A Zmijewski; Jordan Zjawiony; Andrzej Slominski
Journal:  J Steroid Biochem Mol Biol       Date:  2008-10-21       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.